On September 8, Vertex Pharmaceuticals fell 3.1% in regular trading, trading at $527.91 USD/share, with Turnover of $39.125 million.
Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed broad divergence. Among major names, Amgen down 7.52%, Ionis Pharmaceuticals down 7.56%, Moderna, Inc. down 3.13%, AbbVie down 1.58%, while PDS Biotechnology Corporation surged 176.68%. Large-cap biotech stocks were broadly under pressure, with Vertex Pharmaceuticals tracking the sector-wide weakness.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)